Blaszkewicz M - Search Results

1

Unraveling ambiguous NAT2 genotyping data.

Agúndez JA, Golka K, Martínez C, Selinski S, Blaszkewicz M, García-Martín E. Agúndez JA, et al. Among authors: blaszkewicz m. Clin Chem. 2008 Aug;54(8):1390-4. doi: 10.1373/clinchem.2008.105569. Clin Chem. 2008. PMID: 18664443 Free article.

2

Overrepresentation of the slow acetylator phenotype in painters suffering from urinary bladder cancer.

Golka K, Kempkes M, Flieger A, Blaszkewicz M, Bolt HM. Golka K, et al. Among authors: blaszkewicz m. Med Lav. 1997 Sep-Oct;88(5):425-6. Med Lav. 1997. PMID: 9489306 No abstract available.

3

N-acetyltransferase 2 phenotype in painters with bladder cancer and controls.

Golka K, Weistenhofer W, Jedrusik P, Geller F, Blaszkewicz M, Bolt HM. Golka K, et al. Among authors: blaszkewicz m. Ann Acad Med Singap. 2001 Sep;30(5):464-7. Ann Acad Med Singap. 2001. PMID: 11603126

4

The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: a review considering ethnic differences.

Golka K, Prior V, Blaszkewicz M, Bolt HM. Golka K, et al. Among authors: blaszkewicz m. Toxicol Lett. 2002 Mar 10;128(1-3):229-41. doi: 10.1016/s0378-4274(01)00544-6. Toxicol Lett. 2002. PMID: 11869833 Review.

5

Re-investigation of the concordance of human NAT2 phenotypes and genotypes.

Bolt HM, Selinski S, Dannappel D, Blaszkewicz M, Golka K. Bolt HM, et al. Among authors: blaszkewicz m. Arch Toxicol. 2005 Apr;79(4):196-200. doi: 10.1007/s00204-004-0622-8. Epub 2004 Nov 19. Arch Toxicol. 2005. PMID: 15558239

6

Reconstruction of N-acetyltransferase 2 haplotypes using PHASE.

Golka K, Blaszkewicz M, Samimi M, Bolt HM, Selinski S. Golka K, et al. Among authors: blaszkewicz m. Arch Toxicol. 2008 Apr;82(4):265-70. doi: 10.1007/s00204-007-0247-9. Epub 2007 Sep 19. Arch Toxicol. 2008. PMID: 17879084

7

The influence of polymorphisms of glutathione S-transferases M1 and M3 on the development of human urothelial cancer.

Golka K, Schmidt T, Seidel T, Dietrich H, Roemer HC, Lohlein D, Reckwitz T, Sokeland J, Weistenhofer W, Blaszkewicz M, Selinski S. Golka K, et al. Among authors: blaszkewicz m. J Toxicol Environ Health A. 2008;71(13-14):881-6. doi: 10.1080/15287390801988087. J Toxicol Environ Health A. 2008. PMID: 18569590

8

Glutathione S-transferase P1 ILE105Val polymorphism in occupationally exposed bladder cancer cases.

Kopps S, Angeli-Greaves M, Blaszkewicz M, Prager HM, Roemer HC, Lohlein D, Weistenhofer W, Bolt HM, Golka K. Kopps S, et al. Among authors: blaszkewicz m. J Toxicol Environ Health A. 2008;71(13-14):898-901. doi: 10.1080/15287390801988483. J Toxicol Environ Health A. 2008. PMID: 18569592

9

N-acetyltransferase-2 and medical history in bladder cancer cases with a suspected occupational disease (BK 1301) in Germany.

Weistenhofer W, Blaszkewicz M, Bolt HM, Golka K. Weistenhofer W, et al. Among authors: blaszkewicz m. J Toxicol Environ Health A. 2008;71(13-14):906-10. doi: 10.1080/15287390801988681. J Toxicol Environ Health A. 2008. PMID: 18569594

10

UDP-glucuronosyltransferase 2B7 C802T (His268Tyr) polymorphism in bladder cancer cases.

Zimmermann A, Blaszkewicz M, Roth G, Seidel T, Dietrich H, Schutschkow O, Bolt HM, Golka K. Zimmermann A, et al. Among authors: blaszkewicz m. J Toxicol Environ Health A. 2008;71(13-14):911-4. doi: 10.1080/15287390801988772. J Toxicol Environ Health A. 2008. PMID: 18569595

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

139 results

Search Page